Israel Englander’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30.7M | Sell |
438,615
-580,593
| -57% | -$30M | 0.01% | 1256 |
|
|
2026
Q1 | $51.8M | Buy |
1,019,208
+615,573
| +153% | +$28.7M | 0.02% | 806 |
|
|
2025
Q4 | $11.9M | Sell |
403,635
-763,825
| -65% | -$20.8M | 0.01% | 2078 |
|
|
2025
Q3 | $30.2M | Buy |
1,167,460
+297,968
| +34% | +$8.31M | 0.01% | 1255 |
|
|
2025
Q2 | $24M | Buy |
869,492
+720,698
| +484% | +$19M | 0.01% | 1403 |
|
|
2025
Q1 | $4.22M | Sell |
148,794
-980,074
| -87% | -$34.8M | ﹤0.01% | 3033 |
|
|
2024
Q4 | $46.9M | Buy |
1,128,868
+978,550
| +651% | +$46.8M | 0.02% | 819 |
|
|
2024
Q3 | $10M | Buy |
150,318
+101,120
| +206% | +$9.28M | ﹤0.01% | 2179 |
|
|
2024
Q2 | $5.84M | Sell |
49,198
-46,690
| -49% | -$5.91M | ﹤0.01% | 2582 |
|
|
2024
Q1 | $10.2M | Buy |
95,888
+33,226
| +53% | +$3.35M | ﹤0.01% | 2171 |
|
|
2023
Q4 | $6.23M | Buy |
62,662
+7,601
| +14% | +$639K | ﹤0.01% | 2600 |
|
|
2023
Q3 | $5.69M | Sell |
55,061
-105,902
| -66% | -$11.8M | ﹤0.01% | 2581 |
|
|
2023
Q2 | $19.6M | Buy |
160,963
+41,872
| +35% | +$5.59M | 0.01% | 1415 |
|
|
2023
Q1 | $18.3M | Sell |
119,091
-23,098
| -16% | -$3.81M | 0.01% | 1399 |
|
|
2022
Q4 | $25.5M | Sell |
142,189
-66,123
| -32% | -$10.8M | 0.01% | 1240 |
|
|
2022
Q3 | $24.6M | Sell |
208,312
-79,599
| -28% | -$12.1M | 0.01% | 1154 |
|
|
2022
Q2 | $41.1M | Buy |
287,911
+158,275
| +122% | +$22.6M | 0.03% | 768 |
|
|
2022
Q1 | $22.3M | Sell |
129,636
-144,081
| -53% | -$24.3M | 0.01% | 1276 |
|
|
2021
Q4 | $69.5M | Buy |
273,717
+89,389
| +48% | +$26.1M | 0.04% | 544 |
|
|
2021
Q3 | $70.9M | Sell |
184,328
-234,577
| -56% | -$86.5M | 0.04% | 457 |
|
|
2021
Q2 | $98.4M | Buy |
418,905
+338,679
| +422% | +$60.5M | 0.06% | 307 |
|
|
2021
Q1 | $10.5M | Sell |
80,226
-476,983
| -86% | -$69.1M | 0.01% | 1721 |
|
|
2020
Q4 | $58.2M | Buy |
557,209
+485,385
| +676% | +$49.1M | 0.04% | 383 |
|
|
2020
Q3 | $5.08K | Sell |
71,824
-476,153
| -87% | -$33.2M | 0.01% | 1829 |
|
|
2020
Q2 | $35.2M | Sell |
547,977
-68,434
| -11% | -$3.75M | 0.05% | 450 |
|
|
2020
Q1 | $18.5M | Buy |
+616,411
| New | +$14.2M | 0.04% | 491 |
|
|
2019
Q3 | – | Sell |
-97,027
| Closed | -$1.42M | – | 4412 |
|
|
2019
Q2 | $1.42M | Buy |
97,027
+68,323
| +238% | +$1.47M | ﹤0.01% | 2608 |
|
|
2019
Q1 | $584K | Sell |
28,704
-148,536
| -84% | -$2.76M | ﹤0.01% | 3174 |
|
|
2018
Q4 | $2.71M | Buy |
+177,240
| New | +$2.91M | ﹤0.01% | 2011 |
|
Other funds holding MRNA
TP
Israel Englander's MRNA Position: Q2 2026 in Review
Israel Englander reduced its Moderna (MRNA) stake by 57% in Q2 2026, selling an estimated $30M and leaving 438,615 shares worth $30.7M. The position accounts for 0.01% of the portfolio, ranked #1256.
Israel Englander first reported a position in MRNA in Q4 2018 and has held it in 29 quarters since. The position peaked at $98.4M in Q2 2021. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Israel Englander held 438,615 shares of Moderna worth $30.7M as of Q2 2026.
- Israel Englander sold 580,593 Moderna shares in Q2 2026, an estimated $30M.
- Moderna made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1256 holding.
- Israel Englander first reported a position in Moderna in Q4 2018 and has held it in 29 quarters since.
- Israel Englander's Moderna position peaked at $98.4M in Q2 2021.
- 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.